Compare NTB & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NTB | PLSE |
|---|---|---|
| Founded | 1858 | 2014 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.8B |
| IPO Year | 2016 | 2015 |
| Metric | NTB | PLSE |
|---|---|---|
| Price | $58.70 | $25.51 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $53.75 | $22.00 |
| AVG Volume (30 Days) | 186.3K | ★ 265.5K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.66% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.84 | $840.00 |
| Revenue Next Year | $4.16 | $287.54 |
| P/E Ratio | $9.64 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $40.59 | $12.56 |
| 52 Week High | $59.36 | $28.53 |
| Indicator | NTB | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 58.77 | 53.19 |
| Support Level | $54.30 | $23.60 |
| Resistance Level | N/A | $27.60 |
| Average True Range (ATR) | 1.09 | 1.85 |
| MACD | 0.06 | -0.14 |
| Stochastic Oscillator | 82.71 | 39.25 |
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It offers banking services, comprising retail and corporate banking, and wealth management services, which consist of trust, private banking, and asset management business. The company operates through four reportable segments: Bermuda, Cayman, Channel Islands and the UK, and Other. In its Bermuda and Cayman segments, the company offers retail banking and wealth management services. In the Channel Islands and the UK segment, the company offers retail and corporate banking and wealth management services, and the Other segment includes its operations in the Bahamas, Canada, Mauritius, Singapore, and Switzerland. Maximum revenue for the company is generated from its business in Bermuda.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.